[NKTR] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -109.90%
YoY- -257.95%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 23,315 28,222 39,826 27,762 1,087,717 38,018 95,466 -61.02%
PBT -110,187 -119,495 -100,050 -97,043 975,345 -95,527 -33,644 121.01%
Tax -278 -983 -1,838 -900 3,885 265 182 -
NP -109,909 -118,512 -98,212 -96,143 971,460 -95,792 -33,826 119.84%
Tax Rate - - - - -0.40% - - -
Total Cost 133,224 146,734 138,038 123,905 116,257 133,810 129,292 2.02%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -471.41 -419.93 -246.60 -346.31 89.31 -251.96 -35.43 464.17%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.63 -0.68 -0.57 -0.56 5.67 -0.60 -0.21 108.42%
EPS Diluted -0.63 -0.68 -0.57 -0.56 5.33 -0.60 -0.21 108.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.